amobarbital has been researched along with Learning Disabilities in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Learning Disabilities: Conditions characterized by a significant discrepancy between an individual's perceived level of intellect and their ability to acquire new language and other cognitive skills. These may result from organic or psychological conditions. Relatively common subtypes include DYSLEXIA, DYSCALCULIA, and DYSGRAPHIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, GA | 1 |
| Milner, B | 1 |
2 other studies available for amobarbital and Learning Disabilities
| Article | Year |
|---|---|
Psychological and neuropsychological assessment before and after surgery for epilepsy: implications for the management of learning-disabled people.
Topics: Adaptation, Psychological; Amobarbital; Brain; Comorbidity; Epilepsy; Family Health; Functional Late | 2001 |
Disorders of learning and memory after temporal lobe lesions in man.
Topics: Adult; Amnesia; Amobarbital; Brain Diseases; Epilepsy, Temporal Lobe; Hippocampus; Humans; Learning | 1972 |